Christopher Sorli

Prior to joining Acerus, Dr. Sorli was the Vice President of US Medical Affairs & Head of Cardio-Metabolic Disease for Sanofi (NASDAQ: SNY). In this role, he was responsible for all US medical affairs activities for diabetes, cardiovascular issues, metabolic diseases, and integrated care solutions for a diverse portfolio of products at various stages across the product lifecycle. From 2016–2018 he was the Global Medical Lead for New Products with the Diabetes and Cardiovascular Business Unit at Sanofi, where he provided medical input into early clinical development candidates. Prior to his time at Sanofi, Dr. Sorli founded and led the Billings Clinic Diabetes, Endocrinology and Metabolism Center, a large state-wide center of excellence in endocrinology in Montana. While in clinical practice, one of his clinical specialties was men's health.

Dr. Sorli completed his medical training at the University of Massachusetts Medical School, his internship and residency at Beth Israel Hospital in Boston, and his fellowship at the University of Minnesota. He is Board Certified in Endocrinology, Diabetes and Metabolism, and Internal Medicine. He is nationally and internationally recognized as a Key Opinion Leader for Diabetes, Obesity, and Metabolism. Dr. Sorli has been the principal investigator on numerous industry-sponsored clinical studies, a member of several advisory boards, an invited lecturer, and an FDA AdCom presenter.